GE HEALTHCARE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty approved drugs.
There are three US patents protecting GE HEALTHCARE drugs.
There are seventy-two patent family members on GE HEALTHCARE drugs in twenty-five countries and one hundred and forty-seven supplementary protection certificates in eighteen countries.
Summary for GE HEALTHCARE
| International Patents: | 72 |
| US Patents: | 3 |
| Tradenames: | 57 |
| Ingredients: | 39 |
| NDAs: | 50 |
| Drug Master File Entries: | 5 |
| Patent Litigation for GE HEALTHCARE: | See patent lawsuits for GE HEALTHCARE |
Drugs and US Patents for GE HEALTHCARE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | HYPAQUE-CYSTO | diatrizoate meglumine | SOLUTION;URETHRAL | 016403-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017256-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GE HEALTHCARE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,021,481 | ⤷ Subscribe |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | 4,396,597 | ⤷ Subscribe |
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,250,113 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GE HEALTHCARE Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2008202626 | ⤷ Subscribe |
| European Patent Office | 2182988 | ⤷ Subscribe |
| Brazil | PI0113470 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for GE HEALTHCARE Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1499331 | SPC/GB13/034 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: IZINOVA CONCENTRATE FOR ORAL SOLUTION. THE ACTIVE SUBSTANCE IS A MIXTURE OF 3 SALTS:SODIUM SULPHATE ANHYDROUS, MAGNESIUM SULPHATE HEPTAHYDRATE AND POTASSIUM SULPHATE.; REGISTERED: BE BE434323 20130220; UK PL34926/0016 20130313 |
| 2365988 | 2018C/006 | Belgium | ⤷ Subscribe | PRODUCT NAME: PATIROMER SORBITEX CALCIUM OF EERDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 0788511 | SPC/GB08/036 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: MICAFUNGIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN PARTICULAR MICAFUNGIN SODIUM; REGISTERED: UK EU/1/08/448/001 20080425; UK EU/1/08/448/002 20080425 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
